Van Gossum A, Vahedi K, Staun M, Pertkiewicz M, Shaffer J, Hebuterne X, Beau P, Guedon C, Schmit A, Tjellesen L, Messing B, Forbes A
Medico-surgical Department of Gastroenterology Hôpital Erasme, ULB, Brussels.
Clin Nutr. 2001 Jun;20(3):205-10. doi: 10.1054/clnu.2000.0380.
Home parenteral nutrition (HPN) is a lifesaving treatment in patients with intestinal failure. Dependency of nutritional support becomes permanent for the majority of patients who had received HPN for at least 2 years. The alternative to long term HPN in selected patients is intestinal transplantation.
To study some of the clinical, social and rehabilitation aspects of long-term HPN treatment.
A survey was performed in nine European HPN centres. The questionnaire covered epidemiologic data, underlying diseases, intestinal anatomy, nutritional support and status, marital status, rehospitalization rate, HPN complications, rehabilitation score, drugs use, coexistent diseases and interest in intestinal transplantation. For some items, data were collected within 12 months prior to the evaluation.
This survey included 228 patients with a median age of 49 years. The median duration of HPN was 7 years (range 2--24 years). Short bowel length less than 100 cm was reported in 65% of patients with a predominance of end-jejunostomy or jejuno-colonic anastomosis. Global subjective nutritional status was normal in 79% of the patients, who were supplied with a mean number of 5.6 bags of parenteral nutrition weekly. Rehospitalizations within the 12 months prior to evaluation accounted for a mean period of 23 days and were due to HPN complications in half of the cases. Catheter-related sepsis was the most frequent HPN-complication. Bone metabolism disorders, which seemed to be more common than liver diseases, were directly related to HPN duration. One-third of the HPN patients was regularly consuming analgesics or opiates. HPN impair complete rehabilitation status but may improve the status of patients who had a very low rehabilitation score before starting HPN. An interest of intestinal transplantation was noted in only 10% of medical teams and in 8% of HPN patients.
This study is the largest European survey on long-term HPN patients with long standing or permanent intestinal failure. Data enlighten clinical, social and rehabilitation aspects of patients who could face the option of intestinal transplantation in the future.
家庭肠外营养(HPN)是治疗肠衰竭患者的一种挽救生命的疗法。对于大多数接受HPN至少2年的患者而言,营养支持依赖会变为永久性。对于部分选定患者,长期HPN的替代方案是肠移植。
研究长期HPN治疗的一些临床、社会和康复方面的情况。
在9个欧洲HPN中心开展了一项调查。问卷涵盖流行病学数据、基础疾病、肠道解剖结构、营养支持及状况、婚姻状况、再住院率、HPN并发症、康复评分、药物使用、并存疾病以及对肠移植的兴趣。对于部分项目,在评估前12个月内收集数据。
本次调查纳入了228例患者,中位年龄为49岁。HPN的中位持续时间为7年(范围2 - 24年)。65%的患者报告小肠长度小于100 cm,以空肠末端造口术或空肠 - 结肠吻合术为主。79%的患者整体主观营养状况正常,这些患者每周平均接受5.6袋肠外营养。评估前12个月内的再住院平均时长为23天,其中半数病例是由HPN并发症所致。导管相关脓毒症是最常见的HPN并发症。骨代谢紊乱似乎比肝脏疾病更常见,且与HPN持续时间直接相关。三分之一的HPN患者定期服用镇痛药或阿片类药物。HPN会妨碍完全康复状态,但可能改善开始HPN前康复评分极低的患者的状况。仅10%的医疗团队及8%的HPN患者对肠移植感兴趣。
本研究是欧洲针对长期存在或永久性肠衰竭的长期HPN患者开展的规模最大的调查。数据揭示了未来可能面临肠移植选择的患者的临床、社会和康复方面的情况。